The first CRISPR therapy approved in the U.S. will treat sickle cell disease
In the world’s first CRISPR-based treatment, genetic tweaks to red blood cells aim to help people with the often debilitating disease.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
